Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: Relevance to neurotoxic insults in Alzheimer's disease

Molecular Biology of the Cell

Volumn 20, Issue 21, 2009, Pages 4611-4619

  Sun, Kai Hui ^a   Lee, Hyoung Gon ^b   Smith, Mark A ^b   Shah, Kavita ^a  

^a PURDUE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN C JUN; PROTEIN P25; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL DEATH; CONTROLLED STUDY; DEREGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN TARGETING;

ALZHEIMER DISEASE; ANIMALS; CELL DEATH; CELL LINE; CYCLIN-DEPENDENT KINASE 5; ENZYME ACTIVATION; FEMALE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, TRANSGENIC; NEURONS; PREGNANCY; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 73949151138     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-05-0433     Document Type: Article

References (48)

1. Alani, R., Brown, P., Binétruy, B., Dosaka, H., Rosenberg, R. K., Angel, P., Karin, M., and Birrer, M. J. (1991). The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol. 11, 6286-6295.
2. Amin, N. D., Albers, W., and Pant, H. C. (2002). Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J. Neurosci. Res. 67, 354-362.
3. Anderson, A. J., Cummings, B. J., and Cotman, C. W. (1994). Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease. Exp. Neurol. 125, 286-295.
4. Anderson, A. J., Su, J. H., and Cotman, C. W. (1996). DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16, 1710-1719.
5. Becker-Hapak, M., McAllister, S. S., and Dowdy, S. F. (2001). TAT-mediated protein transduction into mammalian cells. Methods 24, 247-256.
6. Borsello, T., and Forloni, G. (2007). JNK signalling: a possible target to prevent neurodegeneration. Curr. Pharmaceut. Design 13, 1875-1886.
7. Cheng, G., Whitehead, S. N., Hachinski, V., and Cechetto, D. F. (2006) Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol. Dis. 23, 140-151.
8. Coyle, J. T., and Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
9. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H., and Tsai, L. H. (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483.
10. Cruz, J. C., Kim, D., Moy, L. Y., Dobbin, M. M., Sun, X., Bronson, R. T., and Tsai, L. H. (2006). p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 26, 10536-10541.
11. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
12. Dickson, D. W. (2001). Neuropathology of Alzheimer's disease and other dementias. Clin. Geriatr. Med. 17, 209-228.
13. Eilers, A., Whitfield, J., Babij, C., Rubin, L. L., and Ham, J. (1998). Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18, 1713-1724.
14. Fischer, A., Sananbenesi, F., Pang, P. T., Lu, B., and Tsai, L. H. (2005). Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48, 825-838.
15. Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M., and Rubin, L. L. (1995). A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939.
16. Humbert, S., Lanier, L. M., and Tsai, L. H. (2000). Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport 11, 2213-2216.
17. Kihiko, M. E., Tucker, H. M., Rydel, R. E., and Estus, S. (1999). c-Jun contributes to amyloid beta-induced neuronal apoptosis but is not necessary for amyloid beta-induced c-jun induction. J. Neurochem. 73(6), 2609-2612.
18. Klementiev, B., Novikova, T., Novitskaya, V., Walmod, P. S., Dmytriyeva, O., Pakkenberg, B., Berezin, V., and Bock, E. (2007). A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by A beta 25-35. Neuroscience 145, 209-224.
19. Kubo, T., Nishimura, S., Kumagae, Y., and Kaneko, I. (2002). In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J. Neurosci. Res. 70, 474-483.
20. Lagalwar, S., Guillozet-Bongaarts, A. L., Berry, R. W., and Binder, L. I. (2006). Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 455-464.
21. Lee, M. S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., and Tsai, L. H. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
22. Lew, J., Huang, Q. Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., and Wang, J. H. (1994). A brain-specific activator of cyclin-dependent kinase 5. Nature 371, 423-426.
23. Li, B. S., Zhang, L., Takahashi, S., Ma, W., Jaffe, H., Kulkarni, A. B., and Pant, H. C. (2002). Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333.
24. Martín, G., Seguí, J., Díaz-Villoslada, P., Montalbán, X., Planas, A. M., and Ferrer, I. (1996). Jun expression is found in neurons located in the vicinity of subacute plaques in patients with multiple sclerosis. Neurosci. Lett. 212, 95-98.
25. Monaco, E. A., 3rd. (2004). Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer's disease. Curr. Alzheimer Res. 1, 33-38.
26. Muyllaert, D., Terwel, D., Kremer, A., Sennvik, K., Borghgraef, P., Devijver, H., Dewachter, I., and Van Leuven, F. (2008). Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration. Am. J. Pathol. 172, 470-485.
27. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. (1998). Transduction of full-length TAT fusion proteins into mammalian cells: TATp27Kip1 induces cell migration. Nat. Med. 4, 1449-1452.
28. Nunomura, A., et al. (2001). Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
29. O'Hare, M. J., Kushwaha, N., Zhang, Y., Aleyasin, H., Callaghan, S. M., Slack, R. S., Albert, P. R., Vincent, I., and Park, D. S. (2005). Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J. Neurosci. 25, 8954-8966.
30. Otth, C., Mendoza-Naranjo, A., Mujica, L., Zambrano, A., Concha, I. I., and Maccioni, R. B. (2003) Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease. Neuroreport 14, 2403-2409.
31. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
32. Pearson, A. G., Byrne, U. T., MacGibbon, G. A., Faull, R. L., and Dragunow, M. (2006). Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci. Lett. 398, 246-250.
33. Petersen, R. B., Nunomura, A., Lee, H. G., Casadesus, G., Perry, G., Smith, M. A., and Zhu, X. (2007). Signal transduction cascades associated with oxidative stress in Alzheimer's disease. J. Alzheimers Dis. 11, 143-152.
34. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., and Cotman, C. W. (1995). Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
35. Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. Q., and Lee, V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183-4187.
36. Qu, D., et al. (2007). Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55, 37-52.
37. Rademakers, R., Sleegers, K., Theuns, J., Van den Broeck, M., Bel Kacem, S., Nilsson, L. G., Adolfsson, R., van Duijn, C. M., Van Broeckhoven, C., and Cruts, M. (2005) Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease. Neurobiol. Aging 26, 1145-1151.
38. Saito, T., Konno, T., Hosokawa, T., Asada, A., Ishiguro, K., and Hisanaga, S. (2007). p25/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons. J. Neurochem. 102, 133-140.
39. Savage, M. J., Lin, Y. G., Ciallella, J. R., Flood, D. G., and Scott, R. W. (2002). Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22, 3376-3385.
40. Shen, C., Chen, Y., Liu, H., Zhang, K., Zhang, T., Lin, A., and Jing, N. (2008). Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J. Biol. Chem. 283, 17721-17730.
41. Shoji, M., Iwakami, N., Takeuchi, S., Waragai, M., Suzuki, M., Kanazawa, I., Lippa, C. F., Ono, S., and Okazawa, H. (2000). JNK activation is associated with intracellular beta amyloid accumulation. Brain Res. Mol. Brain Res. 85, 221-233.
42. Sun, K. H., de Pablo, Y., Vincent, F., Johnson, E. O., Chavers, A. K., and Shah, K. (2008a). Novel genetic tools reveal Cdk5's major role in golgi fragmentation in Alzheimer's disease. Mol. Biol. Cell 19, 3052-3069.
43. Sun, K. H., de Pablo, Y., Vincent, F., and Shah, K. (2008b). Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J. Neurochem. 107, 265-278.
44. Thakur, A., Wang, X., Siedlak, S. L., Perry, G., Smith, M. A., and Zhu, X. (2007). c-Jun phosphorylation in Alzheimer disease. J. Neurosci. Res. 85, 1668-1673.
45. Tsai, L. H., Delalle, I., Caviness, V. S., Jr., Chae, T., and Harlow, E. (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423.
46. Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincón, M., Zheng, T. S., Davis, R. J., Rakic, P., and Flavell, R. A. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
47. Yoshida, H., Hastie, C. J., McLauchlan, H., Cohen, P., and Goedert, M. (2004). Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J. Neurochem. 90, 352-358.
48. Zhu, X., Raina, A. K., Rottkamp, C. A., Aliev, G., Perry, G., Boux, H., and Smith, M. A. (2001) Activation and redistribution of c-jun N-terminal kinase/ stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435-441.